Observational studyThe western journal of emergency medicine2023

Treatment of Factor-Xa Inhibitor-associated Bleeding with Andexanet Alfa or 4 Factor PCC: A Multicenter Feasibility Retrospective Study.

Adam J Singer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.